论文部分内容阅读
多药耐药结核病(MDR-TB)是指患者感染的结核分枝杆菌对异烟肼、利福平等≥2种抗结核药物耐药[1]。广泛耐药结核病(XDR-TB)指除耐多药之外对任何氟喹诺酮类药物以及3种二线注射药物(硫酸卷曲霉素、卡那霉素和阿米卡星)中至少1种具有耐药性的结核分枝杆菌[2]。因M/XDR-TB治疗时间长,治愈率低,多药耐药结核病已经严重影响了国民的身心健康[3]。为了解常州地区2013年多药耐药结核耐药情况,
Multidrug-resistant tuberculosis (MDR-TB) refers to patients infected with Mycobacterium tuberculosis isoniazid, rifampicin ≥ 2 kinds of anti-TB drugs resistant [1]. XDR-TB refers to resistance to at least one of fluoroquinolones and three second-line injections (capreomycin sulfate, kanamycin and amikacin) in addition to MDR Drug-resistant Mycobacterium tuberculosis [2]. Due to the long duration of M / XDR-TB treatment and the low cure rate, MDR-TB has seriously affected the physical and mental health of the population [3]. To understand the multidrug-resistant tuberculosis drug resistance in Changzhou in 2013,